Earnings Preview: KNSA to Report Financial Results Pre-market on October 29
$Kiniksa Pharmaceuticals International(KNSA.US)$ is scheduled to release its financial results pre-market on October 29 ET. Earnings PreviewAnalysts estimate $Kiniksa Pharmaceuticals International(
Press Release: Kiniksa Pharmaceuticals to Report Third Quarter 2024 Financial Results on October 29, 2024
Wells Fargo Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Maintains Target Price $35
Wall Street Analysts Think Kiniksa Pharmaceuticals (KNSA) Could Surge 42.34%: Read This Before Placing a Bet
Express News | Kiniksa Pharmaceuticals Ltd: Board Size Increases From Nine to Ten
Kiniksa Pharmaceuticals International Insider Sold Shares Worth $437,325, According to a Recent SEC Filing
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Delivers Shareholders Stellar 23% CAGR Over 5 Years, Surging 4.7% in the Last Week Alone
Kiniksa Draws Buy at Jefferies on Potential Blockbuster Status for Lead Drug
Jefferies Initiates Kiniksa Pharmaceuticals at Buy With $40 Price Target
Jefferies Initiates Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Announces Target Price $40
Jefferies analyst Roger Song initiates coverage on $Kiniksa Pharmaceuticals International(KNSA.US)$ with a buy rating, and sets the target price at $40.According to TipRanks data, the analyst has a
J.P. Morgan Maintains Kiniksa Pharmaceuticals International(KNSA.US) With Buy Rating, Raises Target Price to $39
J.P. Morgan analyst Anupam Rama maintains $Kiniksa Pharmaceuticals International(KNSA.US)$ with a buy rating, and adjusts the target price from $38 to $39.According to TipRanks data, the analyst has
Kiniksa Pharmaceuticals to Present at 2024 Wells Fargo Healthcare Conference
Roth MKM Says Small-Cap Value Reaches Key Technical Support, Lists 14 "Bullish" Stocks
New Strong Buy Stocks for August 1st
Express News | Kiniksa Pharmaceuticals Ltd : JP Morgan Raises Target Price to $38 From $30
Kiniksa Pharmaceuticals International Insider Sold Shares Worth $578,966, According to a Recent SEC Filing
Kiniksa Pharmaceuticals International(KNSA.US) Officer Sells US$3.49 Million in Common Stock
$Kiniksa Pharmaceuticals International(KNSA.US)$ Officer Patel Sanj K sold 136.12K shares of common stock on Jul 23, 2024 at an average price of $25.65 for a total value of $3.49 million.Source:
Kiniksa Pharmaceuticals International | 10-Q: Q2 2024 Earnings Report
Kiniksa Pharmaceuticals International And Two More Firms Possibly Priced Below Market Value Estimates
There's No Escaping Kiniksa Pharmaceuticals International, Plc's (NASDAQ:KNSA) Muted Revenues Despite A 41% Share Price Rise